Drugs / Intron
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01782508 | Aug 2012 → Dec 2013 | melanoma | Peking University Cancer Hospital & Institute | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intron | “Imatinib (Gleevec) or high dose Interferon (Intron) in treating melanoma” NCT01782508 ↗ |